Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Merck Foundation...

    Merck Foundation partners with Malaysia and India to build healthcare capacity in Africa

    Written by Ruby Khatun Khatun Published On 2018-01-14T09:30:54+05:30  |  Updated On 14 Jan 2018 9:30 AM IST
    Merck Foundation partners with Malaysia and India to build healthcare capacity in Africa

    New Delhi: Merck Foundation (MF), a non-profit company and subsidiary of Merck KGaA Germany, and the University of Malaya (UM), Malaysia's oldest and most established institution of higher learning, signed a Memorandum of Understanding aimed at providing fellowship training for post-graduate medical trainees from Africa and other developing countries.


    The signing ceremony was witnessed by YB Datuk Dr. Mary Yap Kain Ching, Deputy Minister of Higher Education Malaysia.


    Professor Dr. Frank Stangenberg-Haverkamp, Chairman of Executive Board of E-Merck KG and Chairman of Board of Trustees of Merck Foundation said, "We are delighted to partner with the University of Malaya, to provide clinical training and fellowship programmes to young healthcare practitioners from Africa and other developing countries.


    "I strongly believe that building capacity is the right strategy to improve access to quality and equitable healthcare since the lack of professional skills is a key challenge in these nations. We have successfully conducted many educational and fellowship programs in both Africa and Asia since 2012 and we will continue our long-term commitment through our Merck Foundation."


    The MF-UM collaboration formalized today will facilitate academic support to post-graduate medical trainees in the fields of diabetes, oncology, and infertility.


    Dr. Rasha Kelej, Chief Executive Officer of Merck Foundation explained, "This partnership is essential for the sustainability of Merck Foundation programmes - especially 'Merck Cancer Access Program' and 'Merck More Than A Mother' - that serve as platforms to train oncologists and embryologists to improve access to fertility and cancer care in Africa and Asia. I personally believe through this partnership we will be able to make a significant impact on societies and scientific communities in both continents."


    YBhg. Dato' Professor Dr. Adeeba Kamarulzaman, Dean of the Faculty of Medicine, University of Malaya said, "We possess the requisite experience. Our medical faculty has a well-established post-graduate medical training programme that has already produced an international cohort of graduates from Indonesia, India, Mauritius, and the Maldives."


    For MF, the collaboration exemplifies an effort to help improve the quality of healthcare in underserved communities around the world. The Merck Capacity Advancement Programme has benefited over 30,000 medical graduates across Africa and Asia.


    In 2017 alone, MF initiated the following activities in partnership with academia, ministries of health and the offices of First Ladies in more than 35 countries:


    Merck Cancer Access Program:


    Over 30 African physicians received oncology fellowship programmes spanning one to two years, in a bid to help increase the limited number of oncologists in Africa.


    Merck More Than A Mother:


    More than 30 candidates received three-month hands-on training to be embryologists and fertility specialists in Africa and Asia to improve quality, regulated and safe fertility care in developing countries.


    Merck Diabetes and Hypertension Awards:


    Over 50 medical postgraduates will receive a one-year online diploma in diabetes or preventive cardiovascular medicines, as part of the effort to establish a platform of diabetes and hypertension experts in Africa and Asia.


    The awards encouraged participants from African and Asian medical universities to propose innovative concepts for improving early detection and prevention of diabetes and hypertension in their countries. The awards featured their own themes, namely, "Every Day is a Diabetes Day" and "What the Healthy Heart Needs".


    UM post-graduate clinical masters student, Dr. Fu Mei Sian, won the Merck Diabetes Award 2017. MF will be enrolling her in a one-year online post-graduate diploma course in diabetes offered by the University of South Wales, UK.


    Dr. Fu remarked, "I will also have the opportunity to apply for a study grant from Merck Malaysia on the concept paper that won the award. I hope I will be able to publish the study in the future and encourage more people to use the mobile application that is intended to help prevent diabetes complications."


    Dr. Siti Nurbaya Shahrir, who holds a doctorate in Public Health from Universiti Kebangsaan Malaysia won Merck Hypertension Award 2017. She declared, "I am sure the online post-graduate diploma course in preventive cardiovascular medicine will enable me to better serve my country by developing innovative solutions to curb hypertension."

    AfricabuildcapacitydiabetesDr Rasha KelejHealthcareIndiainfertilityMalaysiaMemorandum of UnderstandingMerck FoundationMerck KGaApartnersUniversity of Malaya
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok